Biofrontera Inc. SEC filings BFRIW

Biofrontera Inc. has 365 filings in SEC EDGAR's recent list, going back to May 7, 2021. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (other events). The company's fiscal year ends on December 31.

Biofrontera Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 12, 2026 —
4 Insider transaction Jul 29, 2026 Jul 28, 2026
4 Insider transaction Jul 29, 2026 Jul 28, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
4 Insider transaction Mar 6, 2026 Mar 4, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 11, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 28, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 12, 2025 —
3 Initial insider ownership Sep 30, 2025 Sep 16, 2025
3 Initial insider ownership Sep 30, 2025 Sep 16, 2025
3 Initial insider ownership Sep 30, 2025 Sep 16, 2025
3 Initial insider ownership Sep 30, 2025 Sep 16, 2025
3 Initial insider ownership Sep 26, 2025 Sep 16, 2025
3 Initial insider ownership Sep 26, 2025 Sep 16, 2025
3 Initial insider ownership Sep 25, 2025 Sep 16, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Sep 19, 2025 —
4 Insider transaction Sep 18, 2025 Sep 16, 2025
4 Insider transaction Sep 16, 2025 Sep 15, 2025
3 Initial insider ownership Sep 16, 2025 Aug 25, 2025
4 Insider transaction Sep 16, 2025 Jul 22, 2025
4 Insider transaction Sep 16, 2025 Jul 22, 2025
4 Insider transaction Sep 16, 2025 Jul 22, 2025
4 Insider transaction Sep 16, 2025 Jul 22, 2025
4 Insider transaction Sep 16, 2025 Jul 22, 2025
4 Insider transaction Sep 16, 2025 Jul 22, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 11, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Jul 25, 2025 —
3 Initial insider ownership Jul 9, 2025 Jun 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 13, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 29, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Dec 20, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 6, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 1, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 23, 2024 —
SC 13G Ownership over 5% (passive) Sep 12, 2024 —
4 Insider transaction Jul 16, 2024 Jul 12, 2024
4 Insider transaction Jul 16, 2024 Jul 12, 2024
4 Insider transaction Jul 16, 2024 Jul 12, 2024
4 Insider transaction Jul 16, 2024 Jul 12, 2024
4 Insider transaction Jul 16, 2024 Jul 12, 2024
4 Insider transaction Jul 16, 2024 Jul 12, 2024
SC 13G/A Amended ownership over 5% (passive) May 29, 2024 —
4 Insider transaction May 22, 2024 May 18, 2024
SC 13G Ownership over 5% (passive) May 7, 2024 —
SC 13G Ownership over 5% (passive) Mar 20, 2024 —
SC 13G Ownership over 5% (passive) Mar 20, 2024 —
SC 13G Ownership over 5% (passive) Mar 20, 2024 —
SC 13G Ownership over 5% (passive) Mar 20, 2024 —
SC 13G Ownership over 5% (passive) Mar 15, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
3 Initial insider ownership Aug 22, 2023 Jul 3, 2023
4 Insider transaction May 22, 2023 May 18, 2023
4 Insider transaction May 22, 2023 May 18, 2023
4 Insider transaction Jan 12, 2023 Jan 10, 2023
4 Insider transaction Jan 12, 2023 Nov 14, 2022
3 Initial insider ownership Nov 4, 2022 Oct 24, 2022
SC 13G Ownership over 5% (passive) Nov 4, 2022 —
SC 13D/A Amended ownership over 5% (active) Sep 19, 2022 —
4 Insider transaction Sep 19, 2022 Jul 1, 2022
4 Insider transaction Sep 19, 2022 Aug 22, 2022
SC 13D Ownership over 5% (active) Aug 25, 2022 —
4/A Filing Jun 6, 2022 May 18, 2022
4/A Filing Jun 6, 2022 May 18, 2022
4/A Filing Jun 6, 2022 May 18, 2022
4/A Filing Jun 6, 2022 May 18, 2022
4 Insider transaction May 26, 2022 May 18, 2022
4 Insider transaction May 26, 2022 May 18, 2022
4 Insider transaction May 26, 2022 May 18, 2022
4 Insider transaction May 26, 2022 May 18, 2022
4 Insider transaction May 26, 2022 May 18, 2022
4 Insider transaction May 26, 2022 May 18, 2022
4 Insider transaction May 26, 2022 May 18, 2022
3 Initial insider ownership Mar 14, 2022 Mar 2, 2022
SC 13G Ownership over 5% (passive) Feb 10, 2022 —
4/A Filing Jan 19, 2022 Dec 9, 2021
4/A Filing Jan 19, 2022 Dec 9, 2021
4 Insider transaction Jan 19, 2022 Dec 9, 2021
4 Insider transaction Dec 13, 2021 Dec 9, 2021
4 Insider transaction Dec 13, 2021 Dec 9, 2021
3 Initial insider ownership Nov 2, 2021 Nov 2, 2021
3 Initial insider ownership Nov 2, 2021 Nov 2, 2021
3 Initial insider ownership Nov 2, 2021 Nov 2, 2021
3 Initial insider ownership Oct 28, 2021 Oct 28, 2021
3 Initial insider ownership Oct 28, 2021 Oct 28, 2021
3 Initial insider ownership Oct 28, 2021 Oct 28, 2021
3 Initial insider ownership Oct 28, 2021 Oct 28, 2021

Showing 96 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
BFRI (Nasdaq), BFRIW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Woburn, MA
SEC filer status
, Emerging growth company
SEC CIK
1858685

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.